logo
episode-header-image
Jun 2023
7m 1s

CAR-T Treatment in Myeloma: State of the...

European Hematology Association
About this episode
tail spinning
Up next
Oct 30
How Experts Treat Follicular Lymphoma
Follicular lymphoma (FL) is entering a new era: from decades of chemotherapy to increasingly effective, less toxic biological and immunotherapy-based approaches. In this podcast episode of EHA Unplugged, hear directly from the authors of the latest EHA guidelines on FL: Prof Marc ... Show More
19m 3s
Oct 16
How Experts Treat Chronic Lymphocytic Leukemia (CLL)  
Explore the latest EHA guidelines on chronic lymphocytic leukemia (CLL) and Richter transformation with key guideline authors Prof Barbara Eichhorst, hematologist at University Hospital Cologne (Germany), and Prof Paolo Ghia, Director of the CLL Program at Università Vita-Salute ... Show More
14m 39s
Oct 9
How Experts Treat Hodgkin Lymphoma
Stay up to date with the latest EHA guidelines on Hodgkin lymphoma. In this episode of EHA Unplugged, key guideline authors Prof. Dennis Eichenauer and Prof. Igor Aurer discuss the evidence reshaping the management of classic Hodgkin lymphoma. The discussion highlights the guidel ... Show More
12m 19s
Recommended Episodes
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s
Mar 2023
Episode 049: Myeloma Series, Pt.10- Multiple Myeloma Capstone
<p class="" style="white-space:pre-wrap;">It’s been a long road, but incredibly educational journey, through our Myeloma Series. We finish off our series with a bang by sitting down with Multiple Myeloma Superstar, Dr. Manni Mohyuddin. In this episode, Dr. Mohyuddin takes us thro ... Show More
1h 7m
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Mar 2023
Episode 048: Myeloma Series, Pt.9- Transplant in Myeloma Capstone
<p class="" style="white-space:pre-wrap;">In episode 046, we discussed the fundamentals of transplant in the treatment of patients with multiple myeloma. This week, we sit down with two incredible hematologists who specialize in transplant to discuss the real-life decision-making ... Show More
52m 47s
Jan 2023
Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More
34m 19s
Jun 2024
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ... Show More
33m 47s
Feb 2023
Episode 045: Myeloma Series, Pt.6- Myeloma Treatment in Transplant Ineligible Patients
<p class="" style="white-space:pre-wrap;">In this episode, we start with a little bit of story time about the history of myeloma treatments and how we got to the present day. We then finish off the episode with how this information helped us treat transplant ineligible patients. ... Show More
29m 14s
Mar 2024
Innovations in CAR T-Cell Therapy for Multiple Myeloma
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. John Sweetenham and Shaji Kumar discuss the emergence of CAR T-cell therapy for multiple myeloma, its benefits and challenges for patients, and its potential role earlier in the treatment of diseas ... Show More
20m 55s
Dec 2024
263. Cytokines Everywhere All at Once: Approach to CRS and ICANS
Send us Fan MailAs a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition. T ... Show More
17m 17s
Feb 2023
Episode 047: Myeloma Series, Pt.8- Myeloma Maintenance Therapy
tail spinning
30m 11s